19
Purdue Pharmaceuticals L.P, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is HYDROCODONE BITARTRATE, with a corresponding application number 206627.
Regulatory Information RX
With a dosage strength 100MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2014-11-20
Therapeutic Equivalence (TE) Code AB
18
Purdue Pharmaceuticals L.P, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is HYDROCODONE BITARTRATE, with a corresponding application number 206627.
Regulatory Information RX
With a dosage strength 60MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2014-11-20
Therapeutic Equivalence (TE) Code AB
17
Purdue Pharmaceuticals L.P, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is HYDROCODONE BITARTRATE, with a corresponding application number 206627.
Regulatory Information RX
With a dosage strength 30MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2014-11-20
Therapeutic Equivalence (TE) Code AB
16
Purdue Pharmaceuticals L.P, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is HYDROCODONE BITARTRATE, with a corresponding application number 206627.
Regulatory Information RX
With a dosage strength 120MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2014-11-20
Therapeutic Equivalence (TE) Code AB
15
Purdue Pharmaceuticals L.P, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is HYDROCODONE BITARTRATE, with a corresponding application number 206627.
Regulatory Information RX
With a dosage strength 80MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2014-11-20
Therapeutic Equivalence (TE) Code AB
14
Purdue Pharmaceuticals L.P, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is HYDROCODONE BITARTRATE, with a corresponding application number 206627.
Regulatory Information RX
With a dosage strength 40MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2014-11-20
Therapeutic Equivalence (TE) Code AB
13
Purdue Pharmaceuticals L.P, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is HYDROCODONE BITARTRATE, with a corresponding application number 206627.
Regulatory Information RX
With a dosage strength 20MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2014-11-20
Therapeutic Equivalence (TE) Code AB